#Japan #Osaka #Clinical Research #Linical #Patient Welfare

Celebrating 20 Years of Linical

In June 2025, Linical, a prominent leader in clinical research services, proudly commemorates its 20th anniversary. This milestone reflects a steadfast commitment to improving patient outcomes through high-quality, patient-centered research. Founded in Japan in 2005, Linical has transformed from a small team with ambitious goals into a global entity, supporting clinical trials across more than 30 countries.

Since its inception, Linical has aimed for more than simply managing clinical studies; the company sought to create a meaningful impact on patients' lives. Over the years, Linical's offerings have expanded significantly, now including comprehensive clinical trial management, site selection, regulatory support, biometrics, pharmacovigilance, and drug development strategies. Despite its growth, Linical has maintained its core mission: to advance science while prioritizing patient safety and welfare.

Kazuhiro Hatano, the CEO of Linical, stated, "What began as a small company with a handful of dedicated pharmaceutical industry professionals has evolved into a global force in clinical research. We have never lost sight of the fact that at the heart of every clinical trial is a patient hoping for a better future. This continues to motivate us."

Throughout the past two decades, Linical has participated in hundreds of clinical studies across various therapeutic areas, including oncology, neurology, immunology, and rare diseases. By leveraging data-driven technology and processes, the company has expedited the initiation of studies, enhanced site performance, and improved trial quality. Its investments in decentralized trial capabilities and digital tools have positioned Linical at the forefront of innovation, especially in an era where flexibility and accessibility in research are more critical than ever.

Linical attributes its success to a culture of collaboration, strong partnerships with sponsors and sites, and an unwavering focus on patients. "Ultimately, it’s about the people in clinical research," added Hatano. "It’s about the individuals participating in trials, the researchers treating them, and the sponsors developing new treatments. We are proud to be part of this ecosystem and help transform scientific discoveries into tangible benefits for patients."

As it celebrates its 20-year milestone, Linical also looks to the future. The rise of artificial intelligence is poised to transform the clinical research sector. Through ongoing investments in global operations, advanced analytics, and patient-centered technologies, Linical aims to enhance its ability to conduct efficient and high-quality clinical trials that expedite the commercialization of new treatments.

"We are proud of what we have accomplished, but we are even more excited about the future," stated Hatano. "Our work is far from finished, and we remain committed to our goal of improving lives through research."

About Linical

Linical is a global provider of clinical research services that aids biopharmaceutical companies in making innovative treatments available to patients in the APAC region, Europe, and North America. By emphasizing quality, technology, and patient welfare, Linical delivers tailored solutions for clinical trials at all phases and across various therapeutic areas.